A Dark Vector Cognition product

Item 1. FINANCIAL STATEMENTS

127K characters. Original on sec.gov ·

Item 1. FINANCIAL STATEMENTS

The 50 tables in Item 1. FINANCIAL STATEMENTS as one CSV, figures in aligned columns. For subscribers: paste your API key. One API call. Plans from $19 a month, see pricing.

Dow Inc. and Subsidiaries

Consolidated Statements of Income

Three Months Ended
In millions, except per share amounts (Unaudited)Mar 31, 2025Mar 31, 2024
Net sales$10,431$10,765
Cost of sales9,7609,488
Research and development expenses200204
Selling, general and administrative expenses366442
Amortization of intangibles7681
Restructuring and asset related charges - net20845
Equity in earnings (losses) of nonconsolidated affiliates(20)17
Sundry income (expense) - net1361
Interest income2865
Interest expense and amortization of debt discount216199
Income (loss) before income taxes(374)449
Credit for income taxes(84)(89)
Net income (loss)(290)538
Net income attributable to noncontrolling interests1722
Net income (loss) available for Dow Inc. common stockholders$(307)$516
Per common share data:
Earnings (loss) per common share - basic$(0.44)$0.73
Earnings (loss) per common share - diluted$(0.44)$0.73
Weighted-average common shares outstanding - basic706.9704.5
Weighted-average common shares outstanding - diluted706.9705.5
Depreciation$512$481
Capital expenditures$685$714

See Notes to the Consolidated Financial Statements.

Table of Contents

Dow Inc. and Subsidiaries

Consolidated Statements of Comprehensive Income

Three Months Ended
In millions (Unaudited)Mar 31, 2025Mar 31, 2024
Net income (loss)$(290)$538
Other comprehensive income (loss), net of tax
Unrealized gains (losses) on investments32(6)
Cumulative translation adjustments122(122)
Pension and other postretirement benefit plans2017
Derivative instruments(20)(22)
Total other comprehensive income (loss)154(133)
Comprehensive income (loss)(136)405
Comprehensive income attributable to noncontrolling interests, net of tax1722
Comprehensive income (loss) attributable to Dow Inc.$(153)$383

See Notes to the Consolidated Financial Statements.

Table of Contents

Dow Inc. and Subsidiaries

Consolidated Balance Sheets

In millions, except share amounts (Unaudited)Mar 31, 2025Dec 31, 2024
Assets
Current Assets
Cash and cash equivalents$1,465$2,189
Accounts and notes receivable:
Trade (net of allowance for doubtful receivables - 2025: $78; 2024: $95)4,9174,756
Other2,2672,108
Inventories6,7656,544
Other current assets914993
Total current assets16,32816,590
Investments
Investment in nonconsolidated affiliates1,2751,266
Other investments (investments carried at fair value - 2025: $2,042; 2024: $2,047)2,8123,033
Noncurrent receivables418380
Total investments4,5054,679
Property
Property63,24262,121
Less: Accumulated depreciation40,91240,117
Net property22,33022,004
Other Assets
Goodwill8,6198,565
Other intangible assets (net of accumulated amortization - 2025: $5,516; 2024: $5,394)1,6521,721
Operating lease right-of-use assets1,3201,268
Deferred income tax assets1,4601,257
Deferred charges and other assets1,2851,228
Total other assets14,33614,039
Total Assets$57,499$57,312
Liabilities and Equity
Current Liabilities
Notes payable$136$135
Long-term debt due within one year502497
Accounts payable:
Trade4,9254,847
Other1,6911,694
Operating lease liabilities - current330318
Income taxes payable304276
Accrued and other current liabilities2,6982,521
Total current liabilities10,58610,288
Long-Term Debt15,93215,711
Other Noncurrent Liabilities
Deferred income tax liabilities407392
Pension and other postretirement benefits - noncurrent4,7004,736
Asbestos-related liabilities - noncurrent688713
Operating lease liabilities - noncurrent1,021984
Other noncurrent obligations6,8706,637
Total other noncurrent liabilities13,68613,462
Stockholders’ Equity
Common stock (authorized 5,000,000,000 shares of $0.01 par value each; issued 2025: 785,933,796 shares; 2024: 784,471,939 shares)88
Additional paid-in capital9,1959,203
Retained earnings20,10120,909
Accumulated other comprehensive loss(7,956)(8,110)
Treasury stock at cost (2025: 79,072,058 shares; 2024: 80,859,145 shares)(4,560)(4,655)
Dow Inc.’s stockholders’ equity16,78817,355
Noncontrolling interests507496
Total equity17,29517,851
Total Liabilities and Equity$57,499$57,312

See Notes to the Consolidated Financial Statements.

Table of Contents

Dow Inc. and Subsidiaries

Consolidated Statements of Cash Flows

In millions (Unaudited)Three Months Ended
Mar 31, 2025Mar 31, 2024
Operating Activities
Net income (loss)$(290)$538
Adjustments to reconcile net income (loss) to net cash provided by operating activities:
Depreciation and amortization714720
Provision (credit) for deferred income tax(177)7
Earnings of nonconsolidated affiliates less than dividends received13375
Net periodic pension benefit credit(26)(48)
Pension contributions(31)(34)
Net gain on sales of assets, businesses and investments(2)(11)
Restructuring and asset related charges - net20845
Other net loss18592
Changes in assets and liabilities, net of effects of acquired and divested companies:
Accounts and notes receivable(301)(600)
Inventories(221)(297)
Accounts payable38398
Other assets and liabilities, net(126)(425)
Cash provided by operating activities - continuing operations104460
Cash provided by (used for) operating activities - discontinued operations(13)4
Cash provided by operating activities91464
Investing Activities
Capital expenditures(685)(714)
Investment in gas field developments(30)(52)
Proceeds from sales of property, businesses and consolidated companies, net of cash divested32
Investments in and loans to nonconsolidated affiliates(3)(2)
Purchases of investments(104)(679)
Proceeds from sales and maturities of investments4161,173
Other investing activities, net21
Cash used for investing activities(401)(271)
Financing Activities
Changes in short-term notes payable(1)(20)
Proceeds from issuance of short-term debt greater than three months117
Payments on short-term debt greater than three months(6)—
Proceeds from issuance of long-term debt1,0131,381
Payments on long-term debt(957)(93)
Collections on securitization programs, net of remittances154
Purchases of treasury stock—(200)
Proceeds from issuance of stock—42
Transaction financing, debt issuance and other costs(64)(11)
Employee taxes paid for share-based payment arrangements(16)(37)
Distributions to noncontrolling interests(22)(14)
Dividends paid to stockholders(494)(493)
Cash provided by (used for) financing activities(521)566
Effect of exchange rate changes on cash, cash equivalents and restricted cash123(54)
Summary
Increase (decrease) in cash, cash equivalents and restricted cash(708)705
Cash, cash equivalents and restricted cash at beginning of period2,2633,048
Cash, cash equivalents and restricted cash at end of period$1,555$3,753
Less: Restricted cash and cash equivalents, included in "Other current assets"9030
Cash and cash equivalents at end of period$1,465$3,723

See Notes to the Consolidated Financial Statements.

Table of Contents

Dow Inc. and Subsidiaries

Consolidated Statements of Equity

Three Months Ended
In millions, except per share amounts (Unaudited)Mar 31, 2025Mar 31, 2024
Common Stock
Balance at beginning and end of period$8$8
Additional Paid-in Capital
Balance at beginning of period9,2038,880
Common stock issued/sold—42
Stock-based compensation8787
Treasury stock issuances - compensation and benefit plans(95)(67)
Balance at end of period9,1958,942
Retained Earnings
Balance at beginning of period20,90921,774
Net income (loss) available for Dow Inc. common stockholders(307)516
Dividends to stockholders(494)(493)
Common control transaction—10
Other(7)(11)
Balance at end of period20,10121,796
Accumulated Other Comprehensive Loss
Balance at beginning of period(8,110)(7,681)
Other comprehensive income (loss)154(133)
Balance at end of period(7,956)(7,814)
Treasury Stock
Balance at beginning of period(4,655)(4,374)
Treasury stock purchases—(200)
Treasury stock issuances - compensation and benefit plans9567
Balance at end of period(4,560)(4,507)
Dow Inc.'s stockholders' equity16,78818,425
Noncontrolling Interests507492
Total Equity$17,295$18,917
Dividends declared per share of common stock$0.70$0.70

See Notes to the Consolidated Financial Statements.

Table of Contents

The Dow Chemical Company and Subsidiaries

Consolidated Statements of Income

Three Months Ended
In millions (Unaudited)Mar 31, 2025Mar 31, 2024
Net sales$10,431$10,765
Cost of sales9,7599,487
Research and development expenses200204
Selling, general and administrative expenses366442
Amortization of intangibles7681
Restructuring and asset related charges - net20845
Equity in earnings (losses) of nonconsolidated affiliates(20)17
Sundry income (expense) - net1361
Interest income2969
Interest expense and amortization of debt discount216199
Income (loss) before income taxes(372)454
Credit for income taxes(84)(89)
Net income (loss)(288)543
Net income attributable to noncontrolling interests1722
Net income (loss) available for The Dow Chemical Company common stockholder$(305)$521
Depreciation$512$481
Capital expenditures$685$714

See Notes to the Consolidated Financial Statements.

Table of Contents

The Dow Chemical Company and Subsidiaries

Consolidated Statements of Comprehensive Income

Three Months Ended
In millions (Unaudited)Mar 31, 2025Mar 31, 2024
Net income (loss)$(288)$543
Other comprehensive income (loss), net of tax
Unrealized gains (losses) on investments32(6)
Cumulative translation adjustments122(122)
Pension and other postretirement benefit plans2017
Derivative instruments(20)(22)
Total other comprehensive income (loss)154(133)
Comprehensive income (loss)(134)410
Comprehensive income attributable to noncontrolling interests, net of tax1722
Comprehensive income (loss) attributable to The Dow Chemical Company$(151)$388

See Notes to the Consolidated Financial Statements.

Table of Contents

The Dow Chemical Company and Subsidiaries

Consolidated Balance Sheets

In millions, except share amounts (Unaudited)Mar 31, 2025Dec 31, 2024
Assets
Current Assets
Cash and cash equivalents$1,465$2,189
Accounts and notes receivable:
Trade (net of allowance for doubtful receivables - 2025: $78; 2024: $95)4,9174,756
Other2,2702,116
Inventories6,7656,544
Other current assets858960
Total current assets16,27516,565
Investments
Investment in nonconsolidated affiliates1,2751,266
Other investments (investments carried at fair value - 2025: $2,042; 2024: $2,047)2,8123,033
Noncurrent receivables412374
Total investments4,4994,673
Property
Property63,24262,121
Less accumulated depreciation40,91240,117
Net property22,33022,004
Other Assets
Goodwill8,6198,565
Other intangible assets (net of accumulated amortization - 2025: $5,516; 2024: $5,394)1,6521,721
Operating lease right-of-use assets1,3201,268
Deferred income tax assets1,4601,257
Deferred charges and other assets1,2851,228
Total other assets14,33614,039
Total Assets$57,440$57,281
Liabilities and Equity
Current Liabilities
Notes payable$136$135
Long-term debt due within one year502497
Accounts payable:
Trade4,9254,847
Other1,7081,732
Operating lease liabilities - current330318
Income taxes payable304276
Accrued and other current liabilities2,5972,405
Total current liabilities10,50210,210
Long-Term Debt15,93215,711
Other Noncurrent Liabilities
Deferred income tax liabilities407392
Pension and other postretirement benefits - noncurrent4,7004,736
Asbestos-related liabilities - noncurrent688713
Operating lease liabilities - noncurrent1,021984
Other noncurrent obligations6,7336,503
Total other noncurrent liabilities13,54913,328
Stockholder's Equity
Common stock (authorized and issued 100 shares of $0.01 par value each)——
Additional paid-in capital9,7139,626
Retained earnings15,19316,020
Accumulated other comprehensive loss(7,956)(8,110)
The Dow Chemical Company’s stockholder's equity16,95017,536
Noncontrolling interests507496
Total equity17,45718,032
Total Liabilities and Equity$57,440$57,281

See Notes to the Consolidated Financial Statements.

Table of Contents

The Dow Chemical Company and Subsidiaries

Consolidated Statements of Cash Flows

In millions (Unaudited)Three Months Ended
Mar 31, 2025Mar 31, 2024
Operating Activities
Net income (loss)$(288)$543
Adjustments to reconcile net income (loss) to net cash provided by operating activities:
Depreciation and amortization714720
Provision (credit) for deferred income tax(177)7
Earnings of nonconsolidated affiliates less than dividends received13375
Net periodic pension benefit credit(26)(48)
Pension contributions(31)(34)
Net gain on sales of assets, businesses and investments(2)(11)
Restructuring and asset related charges - net20845
Other net loss18592
Changes in assets and liabilities, net of effects of acquired and divested companies:
Accounts and notes receivable(301)(600)
Inventories(221)(297)
Accounts payable38398
Other assets and liabilities, net(120)(421)
Cash provided by operating activities112469
Investing Activities
Capital expenditures(685)(714)
Investment in gas field developments(30)(52)
Proceeds from sales of property, businesses and consolidated companies, net of cash divested32
Investments in and loans to nonconsolidated affiliates(3)(2)
Purchases of investments(104)(679)
Proceeds from sales and maturities of investments4161,173
Other investing activities, net21
Cash used for investing activities(401)(271)
Financing Activities
Changes in short-term notes payable(1)(20)
Proceeds from issuance of short-term debt greater than three months117
Payments on short-term debt greater than three months(6)—
Proceeds from issuance of long-term debt1,0131,381
Payments on long-term debt(957)(93)
Collections on securitization programs, net of remittances154
Proceeds from issuance of stock—42
Transaction financing, debt issuance and other costs(64)(11)
Employee taxes paid for share-based payment arrangements(16)(37)
Distributions to noncontrolling interests(22)(14)
Dividends paid to Dow Inc.(515)(698)
Cash provided by (used for) financing activities(542)561
Effect of exchange rate changes on cash, cash equivalents and restricted cash123(54)
Summary
Increase (decrease) in cash, cash equivalents and restricted cash(708)705
Cash, cash equivalents and restricted cash at beginning of period2,2633,048
Cash, cash equivalents and restricted cash at end of period$1,555$3,753
Less: Restricted cash and cash equivalents, included in "Other current assets"9030
Cash and cash equivalents at end of period$1,465$3,723

See Notes to the Consolidated Financial Statements.

Table of Contents

The Dow Chemical Company and Subsidiaries

Consolidated Statements of Equity

Three Months Ended
In millions (Unaudited)Mar 31, 2025Mar 31, 2024
Common Stock
Balance at beginning and end of period$—$—
Additional Paid-in Capital
Balance at beginning of period9,6269,091
Issuance of parent company stock - Dow Inc.—42
Stock-based compensation8787
Balance at end of period9,7139,220
Retained Earnings
Balance at beginning of period16,02017,495
Net income (loss) available for The Dow Chemical Company common stockholder(305)521
Dividends to Dow Inc.(515)(791)
Other(7)(11)
Balance at end of period15,19317,214
Accumulated Other Comprehensive Loss
Balance at beginning of period(8,110)(7,681)
Other comprehensive income (loss)154(133)
Balance at end of period(7,956)(7,814)
The Dow Chemical Company's stockholder's equity16,95018,620
Noncontrolling Interests507492
Total Equity$17,457$19,112

See Notes to the Consolidated Financial Statements.

Table of Contents

Dow Inc. and Subsidiaries The Dow Chemical Company and Subsidiaries (Unaudited)

NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS

Table of Contents

NotePage
1Consolidated Financial Statements15
2Recent Accounting Guidance16
3Revenue16
4Restructuring and Asset Related Charges - Net18
5Supplementary Information19
6Earnings Per Share Calculations20
7Inventories20
8Transfers of Financial Assets21
9Notes Payable, Long Term Debt and Available Credit Facilities22
10Commitments and Contingencies24
11Leases26
12Accumulated Other Comprehensive Loss27
13Noncontrolling Interests28
14Pension and Other Postretirement Benefit Plans28
15Stock-Based Compensation29
16Financial Instruments29
17Fair Value Measurements33
18Segments and Geographic Regions34

NOTE 1 – CONSOLIDATED FINANCIAL STATEMENTS

Basis of Presentation

Dow Inc. is the direct parent company of The Dow Chemical Company and its consolidated subsidiaries ("TDCC" and together with Dow Inc., "Dow" or the "Company"). The unaudited interim consolidated financial statements of Dow Inc. and TDCC were prepared in accordance with accounting principles generally accepted in the United States of America and reflect all adjustments (including normal recurring accruals) which, in the opinion of management, are considered necessary for the fair presentation of the results for the periods presented. These statements should be read in conjunction with the audited consolidated financial statements and notes thereto included in the combined Dow Inc. and TDCC Annual Report on Form 10-K for the year ended December 31, 2024 ("2024 10-K").

As a result of the parent/subsidiary relationship between Dow Inc. and TDCC, and considering that the financial statements and disclosures of each company are substantially similar, the companies are filing a combined report for this Quarterly Report on Form 10-Q. The information reflected in the report is equally applicable to both Dow Inc. and TDCC, except where otherwise noted. Transactions between TDCC and Dow Inc. are treated as related party transactions for TDCC.

Except as otherwise indicated by the context, the term "Union Carbide" means Union Carbide Corporation and the term "Dow Silicones" means Dow Silicones Corporation, both wholly owned subsidiaries of the Company.

Table of Contents

NOTE 2 – RECENT ACCOUNTING GUIDANCE

Recently Adopted Accounting Guidance

In the fourth quarter of 2024, the Company adopted the annual and interim disclosure requirements of Accounting Standards Update ("ASU") 2023-07, "Segment Reporting (Topic 280): Improvements to Reportable Segment Disclosures." The amendments expand a public business entity's segment disclosures by requiring disclosure of significant segment expenses that are regularly provided to the chief operating decision maker ("CODM"), clarifying when an entity may report one or more additional measures to assess segment performance, requiring enhanced interim disclosures, providing new disclosure requirements for entities with a single reportable segment, and requiring other new disclosures. See Note 18 for applicable reportable segment disclosures required by this guidance.

Accounting Guidance Issued But Not Adopted at March 31, 2025

In December 2023, the Financial Accounting Standards Board ("FASB") issued ASU 2023-09, "Income Taxes (Topic 740): Improvements to Income Tax Disclosures," which is intended to enhance the transparency, decision usefulness and effectiveness of income tax disclosures. The amendments in this ASU require a public business entity to disclose a tabular tax rate reconciliation, using both percentages and currency, with specific categories. A public business entity is also required to provide a qualitative description of the states and local jurisdictions that make up the majority of the effect of the state and local income tax category and the net amount of income taxes paid, disaggregated by federal, state and foreign taxes and also disaggregated by individual jurisdictions. The amendments also remove certain disclosures that are no longer considered cost beneficial. The amendments are effective prospectively for annual periods beginning after December 15, 2024, and early adoption and retrospective application are permitted. The adoption of the ASU is not expected to have a material impact on the Company's consolidated financial statements.

In November 2024, the FASB issued ASU 2024-03, "Income Statement—Reporting Comprehensive Income—Expense Disaggregation Disclosures (Subtopic 220-40): Disaggregation of Income Statement Expenses," which is intended to improve disclosures about a public business entity's expenses and address requests from investors for more detailed information about the types of expenses in commonly presented expense captions. Such information should allow investors to better understand an entity's performance, assess future cash flows, and compare performance over time and with other entities. The amendments will require public business entities to disclose in the notes to the financial statements, at each interim and annual reporting period, specific information about certain costs and expenses, including purchases of inventory, employee compensation, depreciation, and intangible asset amortization included in each expense caption presented on the face of the income statement, and the total amount of an entity's selling expenses. The amendments are effective for annual reporting periods beginning after December 15, 2026, and interim reporting periods beginning after December 15, 2027, and may be applied either prospectively or retrospectively. Early adoption is permitted. The Company is currently evaluating the impact of adopting this guidance on the consolidated financial statements.

SEC Final Rules Not Adopted at March 31, 2025

In March 2024, the U.S. Securities and Exchange Commission ("SEC") adopted final rules under SEC Release Nos. 33-11275 and 34-99678, "The Enhancement and Standardization of Climate-Related Disclosures for Investors," which requires registrants to disclose certain climate-related information in registration statements and annual reports. As a large accelerated filer, most disclosure requirements would be effective for the Company beginning in the year ending December 31, 2025, with certain greenhouse gas emissions disclosures required for the year ending December 31, 2026. In April 2024, the SEC issued an order to stay the final rules until various legal challenges are resolved by the U.S. Court of Appeals for the Eighth Circuit ("Court of Appeals"). In March 2025, the SEC voted to end its defense of the final rules; however, the Court of Appeals may still rule on the matter.

NOTE 3 – REVENUE

Revenue Recognition

The majority of the Company's revenue is derived from product sales. The Company's revenue related to product sales was 97 percent for the three months ended March 31, 2025 (98 percent for the three months ended March 31, 2024). The remaining sales were primarily related to the Company's insurance operations and licensing of patents and technologies. Product sales consist of sales of the Company's products to manufacturers and distributors. The Company considers order confirmations or purchase orders, which in some cases are governed by master supply agreements, to be contracts with a customer. The Company enters into licensing arrangements in which it licenses certain rights of its patents and technology to customers. Revenue from the Company’s licenses for patents and

Table of Contents

technology is derived from sales-based royalties and licensing arrangements based on billing schedules established in each contract.

Remaining Performance Obligations

Remaining performance obligations represent the transaction price allocated to unsatisfied or partially unsatisfied performance obligations. At March 31, 2025, the Company had unfulfilled performance obligations of $769 million ($759 million at December 31, 2024) related to the licensing of technology. The Company expects revenue to be recognized for the remaining performance obligations over the next six years.

The Company has additional remaining performance obligations for product sales that have expected durations of one year or less, product sales of materials delivered through a pipeline for which the Company has elected the "right to invoice" practical expedient, and variable consideration attributable to royalties for licenses of patents and technology. The Company has received advance payments from customers related to long-term supply agreements that are deferred and recognized over the life of the contract, with remaining contract terms that range up to 19 years. The Company will have rights to future consideration for revenue recognized when product is delivered to the customer. These payments are included in "Accrued and other current liabilities" and "Other noncurrent obligations" in the consolidated balance sheets.

Disaggregation of Revenue

The Company disaggregates its revenue from contracts with customers by operating segment and business, as the Company believes it best depicts the nature, amount, timing and uncertainty of its revenue and cash flows. See details in the tables below:

Net Trade Sales by Segment and BusinessThree Months Ended
In millionsMar 31, 2025Mar 31, 2024
Hydrocarbons & Energy$1,578$1,467
Packaging and Specialty Plastics3,7323,963
Packaging & Specialty Plastics$5,310$5,430
Industrial Solutions$1,054$1,028
Polyurethanes & Construction Chemicals1,7971,977
Other43
Industrial Intermediates & Infrastructure$2,855$3,008
Coatings & Performance Monomers$845$885
Consumer Solutions1,2261,267
Performance Materials & Coatings$2,071$2,152
Corporate$195$175
Total$10,431$10,765
Net Trade Sales by Geographic RegionThree Months Ended
In millionsMar 31, 2025Mar 31, 2024
U.S. & Canada$4,227$4,130
EMEAI 13,2743,484
Asia Pacific1,8581,921
Latin America1,0721,230
Total$10,431$10,765

1.Europe, Middle East, Africa and India.

Contract Assets and Liabilities

The Company receives payments from customers based upon contractual billing schedules. Accounts receivable are recorded when the right to consideration becomes unconditional. Contract assets include amounts related to the Company's contractual right to consideration for completed performance obligations not yet invoiced. Contract liabilities include payments received in advance of performance under the contract and are recognized in revenue

Table of Contents

when the performance obligations are met. "Contract liabilities - current" primarily reflects deferred revenue from prepayments from customers for product to be delivered in 12 months or less and royalty payments that are deferred and will be recognized in 12 months or less. "Contract liabilities - noncurrent" includes advance payments that the Company has received from customers related to long-term supply agreements and royalty payments that are deferred and recognized over the life of the contract.

Revenue recognized in the first three months of 2025 from amounts included in contract liabilities at the beginning of the period was approximately $80 million (approximately $40 million in the first three months of 2024). In the first three months of 2025, the amount of contract assets reclassified to receivables as a result of the right to the transaction consideration becoming unconditional was insignificant (no contract assets reclassified to receivables in the first three months of 2024).

The following table summarizes contract assets and liabilities at March 31, 2025 and December 31, 2024:

Contract Assets and LiabilitiesBalance Sheet ClassificationMar 31, 2025Dec 31, 2024
In millions
Accounts and notes receivable - tradeAccounts and notes receivable - trade$4,917$4,756
Contract assets - noncurrentDeferred charges and other assets$—$2
Contract liabilities - currentAccrued and other current liabilities$207$244
Contract liabilities - noncurrentOther noncurrent obligations$1,459$1,480

NOTE 4 – RESTRUCTURING AND ASSET RELATED CHARGES - NET

Charges for restructuring programs and other asset related charges, which include asset impairments, are recorded in "Restructuring and asset related charges - net" in the consolidated statements of income. For additional information on the Company's restructuring programs, see Note 5 to the Consolidated Financial Statements included in the 2024 10-K.

2025 Restructuring Program

On January 27, 2025, the Dow Inc. Board of Directors ("Board") approved targeted actions to further achieve the Company's cost reduction initiatives in response to ongoing macroeconomic uncertainty, while reinforcing its long-term competitiveness across the economic cycle. The actions include a workforce reduction of approximately 1,500 roles. As a result of these actions, in the first quarter of 2025 the Company recorded pretax charges of $207 million for severance and related benefits costs, included in "Restructuring and asset related charges - net" in the consolidated statements of income, related to Corporate. Costs to implement the targeted actions are expected to result in additional cash expenditures of approximately $10 million. These actions are expected to be substantially complete by the end of 2026. At March 31, 2025, $167 million of the restructuring reserve balance was included in "Accrued and other current liabilities" and $40 million was included in "Other noncurrent obligations" in the consolidated balance sheets.

2023 Restructuring Program

Actions related to the restructuring program approved by the Board on January 25, 2023, were substantially complete at the end of the first quarter of 2025, with the exception of certain cash payments that will continue primarily through the second quarter of 2025. In the first quarter of 2025, the Company recorded an additional pretax restructuring charge of $5 million for asset write-downs and write-offs and an asset related credit adjustment of $4 million, included in "Restructuring and asset related charges - net" in the consolidated statements of income, related to Industrial Intermediates & Infrastructure. See Note 17 for additional information on nonrecurring fair value measurements. Restructuring implementation and efficiency costs totaled $50 million for the three months ended March 31, 2025 ($46 million for the three months ended March 31, 2024).

Subsequent Event

On April 24, 2025, the Company announced actions to further address the impact on the Company from ongoing macroeconomic volatility and slower GDP growth. The actions include the expansion of the previously announced strategic review of select European assets, which is focused on addressing the persistently challenging demand dynamics and regulatory environment in the geographic region. The Company expects to complete the review of its European assets and announce final actions by mid-2025, and has initially identified three assets it believes will require further action. The assets identified represent higher-cost, energy intensive upstream portions of the

Table of Contents

Company’s portfolio, and include an ethylene facility in Böhlen, Germany (Packaging & Specialty Plastics), chlor-alkali and vinyl assets in Schkopau, Germany (Industrial Intermediates & Infrastructure), and a basics siloxanes plant in Barry, United Kingdom (Performance Materials & Coatings). The assets will be evaluated for potential idle or shut down. The assets have a total net book value of approximately $275 million and the Company will assess the potential impact of the actions on the assets’ carrying values as the review progresses.

NOTE 5 – SUPPLEMENTARY INFORMATION

Dow Inc. Sundry Income (Expense) – NetThree Months Ended
In millionsMar 31, 2025Mar 31, 2024
Non-operating pension and other postretirement benefit plan net credits 1$38$61
Foreign exchange gains (losses) 27(23)
Gain (loss) on sales of other assets and investments(3)9
Loss on early extinguishment of debt 3(60)—
Other - net3114
Total sundry income (expense) – net$13$61

1.See Note 14 for additional information.

2.Foreign exchange losses for the three months ended March 31, 2024 relate primarily to exposures in the Egyptian pound and Argentine peso.

3.See Note 9 for additional information.

Sundry income (expense) - net for TDCC for the three months ended March 31, 2025 and 2024 is substantially the same as that of Dow Inc. and, therefore, Sundry income (expense) - net for TDCC is not disclosed separately.

Other Investments

The Company has investments in company-owned life insurance policies, which are recorded at their cash surrender value as of each balance sheet date, as provided below:

Investments in Company-Owned Life InsuranceMar 31, 2025Dec 31, 2024
In millions
Gross cash value$544$558
Less: Existing drawdowns 1200—
Investments in company-owned life insurance 2$344$558

1.Classified as "Proceeds from sales and maturities of investments" in the consolidated statements of cash flows.

2.Classified as "Other investments" in the consolidated balance sheets.

Supplier Finance Program

The Company facilitates a supply chain financing (“SCF”) program in the ordinary course of business in order to extend payment terms with vendors. Under the terms of this program, a vendor can voluntarily enter into an agreement with a participating financial intermediary to sell its receivables due from the Company. The vendor receives payment from the financial intermediary, and the Company pays the financial intermediary on the terms originally negotiated with the vendor, which generally range from 90 to 120 days. The vendor negotiates the terms of the agreements directly with the financial intermediary and the Company is not a party to that agreement. The financial intermediary may allow the participating vendor to utilize the Company’s creditworthiness in establishing credit spreads and associated costs, which may provide the vendor with more favorable terms than they would be able to secure on their own. The Company does not provide guarantees related to the SCF program. At March 31, 2025, outstanding obligations confirmed as valid under the SCF program were $285 million ($291 million at December 31, 2024), included in “Accounts payable – Trade” in the consolidated balance sheets.

Table of Contents

NOTE 6 – EARNINGS PER SHARE CALCULATIONS

The following tables provide earnings per share calculations for Dow Inc. for the three months ended March 31, 2025 and 2024. Earnings per share of TDCC is not presented as this information is not required in financial statements of wholly owned subsidiaries.

Net Income (Loss) for Earnings Per Share CalculationsThree Months Ended
In millionsMar 31, 2025Mar 31, 2024
Net income (loss)$(290)$538
Net income attributable to noncontrolling interests1722
Net income attributable to participating securities 133
Net income (loss) attributable to common stockholders$(310)$513

1.Restricted stock units are considered participating securities due to the Company's practice of paying dividend equivalents on unvested shares.

Earnings (Loss) Per Share - Basic and DilutedThree Months Ended
Dollars per shareMar 31, 2025Mar 31, 2024
Earnings (loss) per common share - basic$(0.44)$0.73
Earnings (loss) per common share - diluted$(0.44)$0.73
Share Count InformationThree Months Ended
Shares in millionsMar 31, 2025Mar 31, 2024
Weighted-average common shares outstanding - basic706.9704.5
Plus dilutive effect of equity compensation plans 1—1.0
Weighted-average common shares outstanding - diluted706.9705.5
Stock units excluded from EPS calculations 214.98.8

1.The three months ended March 31, 2025 reflect a net loss and, as such, the basic share count was used for purposes of calculating earnings per share on a diluted basis.

2.These outstanding stock units were excluded from the calculation of diluted earnings per share because the effect of including them would have been antidilutive.

NOTE 7 – INVENTORIES

The following table provides a breakdown of inventories:

InventoriesMar 31, 2025Dec 31, 2024
In millions
Finished goods$3,947$3,773
Work in process1,3681,323
Raw materials847822
Supplies1,0841,039
Total$7,246$6,957
Adjustment of inventories to the LIFO basis(481)(413)
Total inventories$6,765$6,544

Table of Contents

NOTE 8 – TRANSFERS OF FINANCIAL ASSETS

Accounts Receivable Programs

The Company maintains accounts receivable facilities with various financial institutions, with committed and uncommitted facilities in the United States and a committed facility in Europe (collectively, "the Programs"), which are set to expire in November 2025. Under the terms of the Programs, the Company may sell certain eligible trade accounts receivable at any point in time, up to $900 million for the U.S. committed facility and up to €500 million for the Europe committed facility. Under the terms of the Programs, the Company continues to service the receivables from the customer, but retains no interest in the receivables, and remits payment to the financial institutions. Losses on transfers of receivables were insignificant for the three months ended March 31, 2025 and 2024. The Company also provides a guarantee to the financial institutions for the creditworthiness and collection of the receivables in satisfaction of the facility. See Note 10 for additional information related to guarantees.

The Company has access to accounts receivable discounting facilities that cover certain receivables generated from sales in EMEAI, Asia Pacific and Canada (collectively, "the Facilities"). Under the terms of the Facilities, the Company retains no interest in the transferred receivables once sold and receivables are transferred with limited recourse. The Company continues to service the receivables from the customer and remits payment to the Facilities. Losses on transfers of receivables were insignificant for the three months ended March 31, 2025 and 2024.

The following table provides a summary of cash flows related to the Programs and the Facilities for the three months ended March 31, 2025 and 2024:

Cash Flows Related to Transfers of Accounts ReceivableThree Months Ended
In millionsMar 31, 2025Mar 31, 2024
Proceeds received from new transfers$514$427

The following table provides the balances related to the Programs and the Facilities at March 31, 2025 and December 31, 2024:

Balances Related to Transfers of Accounts ReceivableMar 31, 2025Dec 31, 2024
In millions
Balance outstanding$535$287
Accounts receivable derecognized$511$278
Amounts recognized in the consolidated balance sheets:
Accrued and other current liabilities 1$24$9
  1. Represents amounts collected from customers and not yet remitted by the Company.

Table of Contents

NOTE 9 – NOTES PAYABLE, LONG-TERM DEBT AND AVAILABLE CREDIT FACILITIES

Notes PayableMar 31, 2025Dec 31, 2024
In millions
Notes payable to banks and other lenders$136$135
Period-end average interest rates28.93%36.03%
Long-Term Debt2025 Average RateMar 31, 20252024 Average RateDec 31, 2024
In millions
Promissory notes and debentures:
Final maturity 20255.63%$3335.63%$333
Final maturity 20284.80%6004.80%600
Final maturity 2029 17.53%9517.58%1,368
Final maturity 20302.10%8182.10%818
Final maturity 2031 and thereafter 15.41%10,2095.37%9,192
Other facilities:
Foreign currency notes and loans, various rates and maturities 12.18%2,0942.01%2,540
InterNotes®, varying maturities through 20534.34%6684.31%661
Medium-term notes, maturity 20254.75%14.75%1
Finance lease obligations 2985939
Unamortized debt discount and issuance costs(225)(244)
Long-term debt due within one year 3(502)(497)
Long-term debt$15,932$15,711

1.Cost includes net fair value hedge adjustment gains of $29 million at March 31, 2025 ($9 million at December 31, 2024). See Note 16 for additional information.

2.See Note 11 for additional information.

3.Presented net of current portion of unamortized debt issuance costs.

Maturities of Long-Term Debt for Next Five Years at Mar 31, 2025
In millions
2025$472
2026$149
2027$746
2028$702
2029$1,045
2030$911

2025 Activity

In the first quarter of 2025, the Company issued $1 billion of senior unsecured notes. The offering included $400 million aggregate principal amount of 5.35 percent notes due 2035 and $600 million aggregate principal amount of 5.95 percent notes due 2055. The Company used the proceeds to complete cash tender offers for certain debt securities. In total, $943 million aggregate principal amount was tendered and retired. As a result, the Company recognized a pretax loss of $60 million on the early extinguishment of debt, included in "Sundry income (expense) - net" in the consolidated statements of income, related to Corporate.

In the first quarter of 2025, the Company issued an aggregate principal amount of $13 million of InterNotes®.

Table of Contents

Available Credit Facilities

The following table summarizes the Company's credit facilities:

Committed and Available Credit Facilities at Mar 31, 2025
In millionsCommitted CreditAvailable CreditMaturity DateInterest
Five Year Competitive Advance and Revolving Credit Facility$5,000$5,000November 2028Floating rate
Bilateral Revolving Credit Facility200200September 2025Floating rate
Bilateral Revolving Credit Facility175175September 2025Floating rate
Bilateral Revolving Credit Facility300300November 2025Floating rate
Bilateral Revolving Credit Facility300300February 2026Floating rate
Bilateral Revolving Credit Facility100100March 2026Floating rate
Bilateral Revolving Credit Facility375375October 2026Floating rate
Bilateral Revolving Credit Facility150150November 2026Floating rate
Bilateral Revolving Credit Facility200200November 2026Floating rate
Bilateral Revolving Credit Facility250250March 2027Floating rate
Bilateral Revolving Credit Facility100100May 2027Floating rate
Bilateral Revolving Credit Facility350350June 2027Floating rate
Bilateral Revolving Credit Facility200200September 2027Floating rate
Bilateral Revolving Credit Facility100100October 2027Floating rate
Bilateral Revolving Credit Facility100100November 2027Floating rate
Bilateral Revolving Credit Facility100100March 2028Floating rate
Bilateral Revolving Credit Facility100100March 2028Floating rate
Bilateral Revolving Credit Facility300300May 2028Floating rate
Total committed and available credit facilities$8,400$8,400

Debt Covenants and Default Provisions

There were no material changes to the debt covenants and default provisions related to the Company's outstanding long-term debt and primary, private credit agreements in the first three months of 2025. For additional information on the Company's debt covenants and default provisions, see Note 14 to the Consolidated Financial Statements included in the 2024 10-K.

Table of Contents

NOTE 10 – COMMITMENTS AND CONTINGENCIES

A summary of the Company's commitments and contingencies can be found in Note 15 to the Consolidated Financial Statements included in the 2024 10-K, which is incorporated by reference herein.

Environmental Matters

Accruals for environmental matters are recorded when it is probable that a liability has been incurred and the amount of the liability can be reasonably estimated, based on current law and existing technologies. At March 31, 2025, the Company had accrued obligations of $1,072 million for probable environmental remediation and restoration costs ($1,113 million at December 31, 2024), including $227 million for the remediation of Superfund sites ($234 million at December 31, 2024). This is management’s best estimate of the costs for remediation and restoration with respect to environmental matters for which the Company has accrued liabilities, although it is reasonably possible that the ultimate cost with respect to these particular matters could range up to approximately two times that amount. Consequently, it is reasonably possible that environmental remediation and restoration costs in excess of amounts accrued could have a material impact on the Company's results of operations, financial condition and cash flows. It is the opinion of the Company’s management, however, that the possibility is remote that costs in excess of the range disclosed will have a material impact on the Company’s results of operations, financial condition and cash flows. Inherent uncertainties exist in these estimates primarily due to unknown conditions, changing governmental regulations and legal standards regarding liability, and emerging remediation technologies for handling site remediation and restoration. As new or additional information becomes available and/or certain spending trends become known, management will evaluate such information in determination of the current estimate of environmental liability.

Litigation

Asbestos-Related Matters of Union Carbide Corporation

Each quarter, Union Carbide reviews asbestos-related claims filed, settled and dismissed, as well as average settlement and resolution costs by disease category. Union Carbide also considers additional quantitative and qualitative factors such as the nature of pending claims, trial experience of Union Carbide and other asbestos defendants, current spending for defense and processing costs, significant appellate rulings and legislative developments, trends in the tort system, and their respective effects on expected future resolution costs. Union Carbide's management considers these factors in conjunction with the most recent actuarial study and determines whether a change in the estimate is warranted. Based on Union Carbide's review of 2025 activity, it was determined that no adjustment to the accrual was required at March 31, 2025.

Union Carbide’s total asbestos-related liability for pending and future claims and defense and processing costs was $767 million at March 31, 2025 ($791 million at December 31, 2024). At March 31, 2025, approximately 25 percent of the recorded claim liability related to pending claims and approximately 75 percent related to future claims.

Legacy Matters

The Company is the subject of various complaints related to alleged groundwater contamination based on decades-old sales and applications of certain agricultural chemical products ("Groundwater Matters"). At March 31, 2025, the total liability related to the probable and estimable settlement of alleged Groundwater Matters was $155 million ($155 million at December 31, 2024), which was included in “Accrued and other current liabilities” and "Other noncurrent obligations" in the consolidated balance sheets.

The Company is also the subject of other groundwater contamination complaints, including claims related to 1,4-dioxane. The Company continues to defend itself in this litigation and it has determined that the Company's exposure to liability, if any, is not probable or estimable at March 31, 2025.

Separately, on October 10, 2024, the Company executed a settlement agreement related to arbitration for historical product claims from a divested business. As a result, the Company recorded a pretax charge of $75 million in the third quarter of 2024, which was paid in the fourth quarter of 2024. Arbitration on the matter was concluded on March 11, 2025, and, as a result, the Company recorded an additional pretax charge of $98 million in the first quarter of 2025, included in "Cost of sales" in the consolidated statements of income, related to Corporate, and included in "Accounts payable - Other" in the consolidated balance sheets at March 31, 2025.

Table of Contents

Gain Contingency - Dow v. Nova Chemicals Corporation Ethylene Asset Matter

As a result of a 2019 damages judgment related to the ethylene asset matter, Nova Chemicals Corporation was ordered to pay the Company $1.43 billion Canadian dollars (equivalent to approximately $1.08 billion U.S. dollars), for which the Company received payment in October 2019 and March 2020. At March 31, 2025, $201 million ($201 million at December 31, 2024) was included in "Other noncurrent obligations" in the Company's consolidated balance sheets related to the disputed portion of the damages judgment.

On April 7, 2025, the Court of King's Bench (”Court") in Alberta, Canada, issued a ruling awarding the Company additional compensation for damages incurred through 2018. This ruling builds on the previous $1.08 billion U.S. dollar payout judgment. Dow expects to receive additional cash proceeds exceeding $1 billion U.S. dollars later in 2025. The Court found that Nova failed to operate the companies' jointly-owned ethylene asset in Joffre, Alberta, Canada at full capacity and, furthermore, that Nova violated several contractual agreements related to the Company receiving its share of the asset’s ethylene production. These actions deprived the Company of millions of pounds of ethylene. Nova will appeal the ruling. Although the Company is confident of its chances of defending the damages award on appeal, the Company has not recorded a gain as a result of the ruling.

Guarantees

The following table provides a summary of the final expiration, maximum future payments and recorded liability included in the consolidated balance sheets for guarantees:

GuaranteesMar 31, 2025Dec 31, 2024
In millionsFinal ExpirationMaximum Future PaymentsRecorded LiabilityFinal ExpirationMaximum Future PaymentsRecorded Liability
Guarantees2038$1,661$1502038$1,456$155

Guarantees arise during the ordinary course of business from relationships with customers, accounts receivable facilities and nonconsolidated affiliates when the Company undertakes an obligation to guarantee the performance of others (via delivery of cash or other assets) if specified triggering events occur. With guarantees, such as commercial or financial contracts, non-performance by the guaranteed party triggers the obligation of the Company to make payments to the beneficiary of the guarantee. The majority of the Company’s guarantees relate to debt of nonconsolidated affiliates, which have expiration dates ranging from less than one year to 13 years. The Company’s current expectation is that future payment or performance related to the non-performance of others is considered remote.

The Company maintains accounts receivable facilities with various financial institutions, with committed and uncommitted facilities in the United States and a committed facility in Europe. Under the terms of the Programs, the Company continues to service the receivables from the customers, but retains no interest in the receivables, and remits payment to the financial institutions. The Company also has access to accounts receivable discounting facilities, under which receivables are transferred with limited recourse. The Company’s maximum guaranteed liability for the accounts receivable facilities is $444 million at March 31, 2025 ($239 million at December 31, 2024). The Company expects receivable collections and remittances to occur within the next six months.

TDCC has entered into guarantee agreements related to Sadara, a nonconsolidated affiliate. Sadara reached an agreement with its lenders to re-profile its outstanding project financing debt in the first quarter of 2021. In conjunction with the debt re-profiling, TDCC entered into a guarantee of up to approximately $1.3 billion of Sadara’s debt, proportionate to the Company's 35 percent ownership interest. The debt re-profiling also includes a grace period until June 2026, during which Sadara is obligated to make interest-only payments which are guaranteed by TDCC in proportion to the Company’s 35 percent ownership interest. The Company does not expect to be required to perform under the guarantees. As part of the debt re-profiling, Sadara established a $500 million revolving credit facility guaranteed by Dow, which would be used to fund Dow’s pro-rata share of any potential shortfall during the grace period.

Table of Contents

NOTE 11 – LEASES

For additional information on the Company's leases, see Note 16 to the Consolidated Financial Statements included in the 2024 10-K.

The components of lease cost for operating and finance leases for the three months ended March 31, 2025 and 2024 were as follows:

Lease CostThree Months Ended
In millionsMar 31, 2025Mar 31, 2024
Operating lease cost$106$107
Finance lease cost
Amortization of right-of-use assets - finance3227
Interest on lease liabilities - finance1210
Total finance lease cost4437
Short-term lease cost8074
Variable lease cost255258
Sublease income(2)(2)
Total lease cost$483$474

The following table provides supplemental cash flow and other information related to leases:

Other Lease InformationThree Months Ended
In millionsMar 31, 2025Mar 31, 2024
Cash paid for amounts included in the measurement of lease liabilities:
Operating cash flows for operating leases$112$116
Operating cash flows for finance leases$12$10
Financing cash flows for finance leases$29$30
Right-of-use assets obtained in exchange for lease obligations:
Operating leases$110$100
Finance leases$65$70

Table of Contents

NOTE 12 – ACCUMULATED OTHER COMPREHENSIVE LOSS

The changes in each component of accumulated other comprehensive loss ("AOCL") for the three months ended March 31, 2025 and 2024 were as follows:

Accumulated Other Comprehensive LossThree Months Ended
In millionsMar 31, 2025Mar 31, 2024
Unrealized Gains (Losses) on Investments
Beginning balance$(243)$(253)
Unrealized gains (losses) on investments4015
Tax (expense) benefit(7)(18)
Net unrealized gains (losses) on investments33(3)
(Gains) losses reclassified from AOCL to net income (loss) 1(1)(4)
Tax expense (benefit) 2—1
Net (gains) losses reclassified from AOCL to net income (loss)(1)(3)
Other comprehensive income (loss), net of tax32(6)
Ending balance$(211)$(259)
Cumulative Translation Adjustments
Beginning balance$(2,063)$(1,891)
Gains (losses) on foreign currency translation126(116)
Tax (expense) benefit3(3)
Net gains (losses) on foreign currency translation129(119)
(Gains) losses reclassified from AOCL to net income (loss) 3(7)(3)
Other comprehensive income (loss), net of tax122(122)
Ending balance$(1,941)$(2,013)
Pension and Other Postretirement Benefit Plans
Beginning balance$(5,720)$(5,486)
Gains (losses) arising during the period—(1)
Amortization of net loss and prior service credits reclassified from AOCL to net income (loss) 42622
Tax expense (benefit) 2(6)(4)
Net loss and prior service credits reclassified from AOCL to net income (loss)2018
Other comprehensive income (loss), net of tax2017
Ending balance$(5,700)$(5,469)
Derivative Instruments
Beginning balance$(84)$(51)
Gains (losses) on derivative instruments(15)(33)
Tax (expense) benefit(2)3
Net gains (losses) on derivative instruments(17)(30)
(Gains) losses reclassified from AOCL to net income (loss) 5(4)10
Tax expense (benefit) 21(2)
Net (gains) losses reclassified from AOCL to net income (loss)(3)8
Other comprehensive income (loss), net of tax(20)(22)
Ending balance$(104)$(73)
Total AOCL ending balance$(7,956)$(7,814)

1.Reclassified to "Net sales" and "Sundry income (expense) - net."

2.Reclassified to "Credit for income taxes."

3.Reclassified to "Sundry income (expense) - net."

4.These AOCL components are included in the computation of net periodic benefit cost (credit) of the Company's defined benefit pension and other postretirement benefit plans. See Note 14 for additional information.

5.Reclassified to "Cost of sales," "Sundry income (expense) - net" and "Interest expense and amortization of debt discount."

Table of Contents

NOTE 13 – NONCONTROLLING INTERESTS

Ownership interests in the Company's subsidiaries held by parties other than the Company are presented separately from the Company's equity in the consolidated balance sheets as "Noncontrolling interests." The amount of consolidated net income attributable to the Company and the noncontrolling interests are both presented on the face of the consolidated statements of income.

The following table summarizes the activity for equity attributable to noncontrolling interests for the three months ended March 31, 2025 and 2024:

Noncontrolling InterestsThree Months Ended
In millionsMar 31, 2025Mar 31, 2024
Balance at beginning of period$496$501
Net income attributable to noncontrolling interests1722
Distributions to noncontrolling interests(22)(14)
Cumulative translation adjustments16(16)
Other—(1)
Balance at end of period$507$492

NOTE 14 – PENSION AND OTHER POSTRETIREMENT BENEFIT PLANS

A summary of the Company's pension and other postretirement benefit plans can be found in Note 19 to the Consolidated Financial Statements included in the 2024 10-K. The following table provides the components of the Company's net periodic benefit cost (credit) for all significant plans:

Net Periodic Benefit Cost (Credit) for All Significant PlansThree Months Ended
In millionsMar 31, 2025Mar 31, 2024
Defined Benefit Pension Plans
Service cost$10$14
Interest cost246252
Expected return on plan assets(319)(346)
Amortization of prior service credit(3)(3)
Amortization of net loss4035
Net periodic benefit credit$(26)$(48)
Other Postretirement Benefit Plans
Service cost$1$1
Interest cost911
Amortization of net gain(11)(10)
Net periodic benefit cost (credit)$(1)$2

Net periodic benefit cost (credit), other than the service cost component, is included in "Sundry income (expense) - net" in the consolidated statements of income.

Table of Contents

NOTE 15 – STOCK-BASED COMPENSATION

A summary of the Company's stock-based compensation plans can be found in Note 20 to the Consolidated Financial Statements included in the 2024 10-K.

Stock Incentive Plan

The Company grants stock-based compensation to employees and non-employee directors under the 2019 Stock Incentive Plan, as amended. Most of the Company's stock-based compensation awards are granted in the first quarter of each year.

In the first quarter of 2025, Dow Inc. granted the following stock-based compensation awards to employees:

  • 1.8 million stock options with a weighted-average exercise price of $38.34 per share and a weighted-average fair value of $8.27 per share;

  • 3.0 million restricted stock units with a weighted-average fair value of $38.34 per share; and

  • 2.1 million performance stock units with a weighted-average fair value of $38.46 per share.

Employee Stock Purchase Plan

The Dow Inc. 2021 Employee Stock Purchase Plan (the "2021 ESPP") was adopted by the Dow Inc. Board on February 11, 2021, and approved by stockholders at the Company's annual meeting on April 15, 2021. Under the 2025 annual offering of the 2021 ESPP, most employees will be eligible to purchase shares of common stock of Dow Inc. valued at up to 10 percent of their annual total base salary or wages. The number of shares purchased is determined using the amount contributed by the employee divided by the plan price. The plan price of the stock is equal to 85 percent of the fair market value (closing price) of the common stock at March 31, 2025 (beginning) or October 3, 2025 (ending) of the offering period, whichever is lower.

In the first quarter of 2025, employees subscribed to the right to purchase approximately 3.2 million shares under the 2021 ESPP. The plan price is fixed upon the close of the offering period and will be determined in the fourth quarter of 2025. The shares will be delivered to employees in the fourth quarter of 2025.

NOTE 16 – FINANCIAL INSTRUMENTS

A summary of the Company's financial instruments, risk management policies, derivative instruments and hedging activities can be found in Note 21 to the Consolidated Financial Statements included in the 2024 10-K.

Refer to Note 17 for a summary of the fair value of financial instruments at March 31, 2025 and December 31, 2024.

Debt Securities

The Company's investments in debt securities are primarily classified as available-for-sale. The following table provides investing results from available-for-sale securities for the three months ended March 31, 2025 and 2024:

Investing ResultsThree Months Ended
In millionsMar 31, 2025Mar 31, 2024
Proceeds from sales of available-for-sale securities$154$721
Gross realized gains$2$9
Gross realized losses$(1)$(5)

Table of Contents

The following table summarizes contractual maturities of the Company's investments in debt securities:

Contractual Maturities of Debt Securities at Mar 31, 2025CostFair Value
In millions
Within one year$110$100
One to five years1,1881,094
Six to ten years426412
After ten years524425
Total$2,248$2,031

Equity Securities

There were no material adjustments to the carrying value of the not readily determinable investments for impairment or observable price changes for the three months ended March 31, 2025. There was $3 million of net unrealized losses recognized in earnings on equity securities for the three months ended March 31, 2025 (no unrealized gains or losses for the three months ended March 31, 2024).

Investments in Equity SecuritiesMar 31, 2025Dec 31, 2024
In millions
Readily determinable fair value$11$14
Not readily determinable fair value$149$153

Derivative Instruments

The notional amounts of the Company's derivative instruments at March 31, 2025 and December 31, 2024 were as follows:

Notional Amounts 1Mar 31, 2025Dec 31, 2024
In millions
Derivatives designated as hedging instruments:
Interest rate contracts$757$1,870
Foreign currency contracts$4,080$3,144
Derivatives not designated as hedging instruments:
Interest rate contracts$44$14
Foreign currency contracts$19,738$9,244

1.Notional amounts represent the absolute value of open derivative positions at the end of the period. Multi-leg option positions are reflected at the maximum notional position at expiration.

The notional amounts of the Company's commodity derivatives at March 31, 2025 and December 31, 2024 were as follows:

Commodity Notionals 1Mar 31, 2025Dec 31, 2024Notional Volume Unit
Derivatives designated as hedging instruments:
Hydrocarbon derivatives5.03.2million barrels of oil equivalent
Derivatives not designated as hedging instruments:
Hydrocarbon derivatives1.01.1million barrels of oil equivalent

1.Notional amounts represent the net volume of open derivative positions outstanding at the end of the period.

Maturity Dates of Derivatives Designated as Hedging InstrumentsYear
Interest rate contracts2027
Foreign currency contracts2026
Commodity contracts2028

Table of Contents

The following table provides the fair value and balance sheet classification of derivative instruments at March 31, 2025 and December 31, 2024:

Fair Value of Derivative InstrumentsMar 31, 2025Dec 31, 2024
In millionsGrossCounterparty and Cash Collateral Netting 1Net 2GrossCounterparty and Cash Collateral Netting 1Net 2
Asset derivatives
Derivatives designated as hedging instruments:
Interest rate contracts 3$27$(18)$9$20$(20)$—
Interest rate contracts 425(19)6———
Foreign currency contracts 334(33)133(15)18
Foreign currency contracts 422(21)1———
Commodity contracts 355(25)3025(14)11
Commodity contracts 444(37)746(36)10
Total$207$(153)$54$124$(85)$39
Derivatives not designated as hedging instruments:
Interest rate contracts 4$1$(1)$—$—$—$—
Foreign currency contracts 325(24)174(16)58
Commodity contracts 313(1)1216(1)15
Commodity contracts 44(3)14(3)1
Total$43$(29)$14$94$(20)$74
Total asset derivatives$250$(182)$68$218$(105)$113
Liability derivatives
Derivatives designated as hedging instruments:
Interest rate contracts 5$18$(18)$—$46$(20)$26
Interest rate contracts 619(19)————
Foreign currency contracts 597(33)6475(15)60
Foreign currency contracts 653(21)3240—40
Commodity contracts 536(26)1016(14)2
Commodity contracts 639(37)237(36)1
Total$262$(154)$108$214$(85)$129
Derivatives not designated as hedging instruments:
Interest rate contracts 5$—$—$—$1$—$1
Interest rate contracts 61(1)————
Foreign currency contracts 5178(24)15427(16)11
Commodity contracts 54(1)38(1)7
Commodity contracts 63(3)—4(3)1
Total$186$(29)$157$40$(20)$20
Total liability derivatives$448$(183)$265$254$(105)$149

1.Counterparty and cash collateral amounts represent the estimated net settlement amount when applying netting and set-off rights included in master netting arrangements between the Company and its counterparties and the payable or receivable for cash collateral held or placed with the same counterparty.

2.Represents the net amounts included in the consolidated balance sheets.

3.Included in "Other current assets" in the consolidated balance sheets.

4.Included in "Deferred charges and other assets" in the consolidated balance sheets.

5.Included in "Accrued and other current liabilities" in the consolidated balance sheets.

6.Included in "Other noncurrent obligations" in the consolidated balance sheets.

Table of Contents

Assets and liabilities related to forward contracts, interest rate swaps, currency swaps, options and other conditional or exchange contracts executed with the same counterparty under a master netting arrangement are netted. Collateral accounts are netted with corresponding assets or liabilities, when applicable. The Company posted cash collateral of $12 million at March 31, 2025 ($16 million at December 31, 2024). No cash collateral was posted by counterparties with the Company at March 31, 2025 and December 31, 2024.

The following table summarizes the gain (loss) of derivative instruments in the consolidated statements of income and comprehensive income for the three months ended March 31, 2025 and 2024:

Effect of Derivative InstrumentsGain (loss) recognized in OCI 1Gain (loss) recognized in income 2
Three Months EndedThree Months Ended
In millionsMar 31, 2025Mar 31, 2024Mar 31, 2025Mar 31, 2024
Derivatives designated as hedging instruments:
Fair value hedges:
Interest rate contracts 3, 4$—$—$20$—
Excluded components 3, 5(5)(38)——
Cash flow hedges:
Interest rate contracts 311(1)(2)
Foreign currency contracts 6(6)(13)21
Commodity contracts 66154(8)
Excluded components 5, 6—(6)(1)(1)
Net foreign investment hedges:
Foreign currency contracts(27)2——
Excluded components 5, 727673
Total derivatives designated as hedging instruments$(4)$(33)$31$(7)
Derivatives not designated as hedging instruments:
Foreign currency contracts 7——(56)31
Commodity contracts 6——(5)8
Total return swap 6——(11)22
Total derivatives not designated as hedging instruments$—$—$(72)$61
Total derivatives$(4)$(33)$(41)$54

1.OCI is defined as other comprehensive income (loss).

2.Pretax amounts.

3.Included in "Interest expense and amortization of debt discount" in the consolidated statements of income.

4.Gain (loss) recognized in income of derivatives is offset by gain (loss) recognized in income of the hedged item.

5.The excluded components are related to the time value of the derivatives designated as hedges.

6.Included in "Cost of sales" in the consolidated statements of income.

7.Included in "Sundry income (expense) - net" in the consolidated statements of income.

The following table provides the net after-tax gain (loss) expected to be reclassified from AOCL to income within the next 12 months:

Expected Reclassifications from AOCL within the next 12 monthsMar 31, 2025
In millions
Cash flow hedges:
Interest rate contracts$(3)
Commodity contracts$13
Foreign currency contracts$(1)
Excluded components$(3)
Net foreign investment hedges:
Excluded components$25

Table of Contents

NOTE 17 – FAIR VALUE MEASUREMENTS

A summary of the Company's recurring and nonrecurring fair value measurements can be found in Note 22 to the Consolidated Financial Statements included in the 2024 10-K.

Fair Value Measurements on a Recurring Basis

The following table summarizes the bases used to measure certain assets and liabilities at fair value on a recurring basis:

Fair Value Measurements on a Recurring BasisMar 31, 2025Dec 31, 2024
In millionsFair Value LevelCostGainLossFair ValueCostGainLossFair Value
Assets at fair value:
Cash equivalents:
Held-to-maturity securities 1Level 2$114$—$—$114$96$—$—$96
Money market fundsLevel 2567——5671,164——1,164
Marketable securities 2Level 2393—(53)340453—(70)383
Other investments:
Debt securities: 3
Government debt 4Level 21,10713(115)1,0051,10313(123)993
Corporate bondsLevel 118—(1)1718—(1)17
Corporate bondsLevel 29236(85)8449546(88)872
Corporate bondsLevel 3200—(35)165200—(49)151
Equity securities 3, 5Level 147—11410—14
Derivatives relating to: 6
Interest ratesLevel 2—53—53—20—20
Foreign currencyLevel 2—81—81—107—107
CommoditiesLevel 1—8—8—4—4
CommoditiesLevel 2—108—108—87—87
Total assets at fair value$3,313$3,908
Liabilities at fair value:
Long-term debt including debt due within one year 7Level 2$(16,434)$1,520$(462)$(15,376)$(16,208)$1,487$(484)$(15,205)
Guarantee liability 8Level 3(149)(155)
Derivatives relating to: 6
Interest ratesLevel 2——(38)(38)——(47)(47)
Foreign currencyLevel 2——(328)(328)——(142)(142)
CommoditiesLevel 1——(2)(2)——(1)(1)
CommoditiesLevel 2——(80)(80)——(64)(64)
Total liabilities at fair value$(15,973)$(15,614)

1.The Company's held-to-maturity securities primarily relate to treasury bills and time deposits. At March 31, 2025, $97 million is included in "Cash and cash equivalents" ($96 million at December 31, 2024) and $17 million is included in "Other current assets" (zero at December 31, 2024) in the consolidated balance sheets.

2.The Company’s investments in marketable securities are included in “Other current assets” in the consolidated balance sheets.

3.The Company’s investments in debt securities, which are primarily available-for-sale, and equity securities are included in “Other investments” in the consolidated balance sheets.

4.U.S. Treasury obligations, U.S. agency obligations, U.S. agency mortgage-backed securities and other municipalities’ obligations.

5.Equity securities with a readily determinable fair value.

6.See Note 16 for classification of derivatives in the consolidated balance sheets.

7.Cost includes fair value hedge adjustment gains of $29 million at March 31, 2025 and $9 million at December 31, 2024 on $5,255 million of debt at March 31, 2025 and $5,129 million at December 31, 2024.

8.Estimated liability for TDCC's guarantee of Sadara's debt which is included in "Other noncurrent obligations" in the consolidated balance sheets.

Cost approximates fair value for all other financial instruments.

Table of Contents

For equity securities calculated at net asset value per share (or its equivalent), the Company had $87 million in private market securities and $14 million in real estate at March 31, 2025 ($90 million in private market securities and $15 million in real estate at December 31, 2024). There are no redemption restrictions and the unfunded commitments on these investments were $80 million at March 31, 2025 and $81 million at December 31, 2024.

For assets classified as Level 3 measurements, fair value is based on significant unobservable inputs including assumptions where there is little, if any, market activity. The level 3 asset values represent the fair value of an investment in a corporate bond, accounted for as a debt security.

For liabilities classified as Level 3 measurements, fair value is based on significant unobservable inputs including assumptions where there is little, if any, market activity. The fair value of the Company’s accrued liability related to the guarantee of Sadara’s debt is in proportion to the Company’s 35 percent ownership interest in Sadara. The estimated fair value of the guarantee was calculated using a "with" and "without" method. The fair value of the debt was calculated "with" the guarantee less the fair value of the debt "without" the guarantee. The "with" and "without" values were calculated using a discounted cash flow method based on contractual cash flows as well as projected prepayments made on the debt by Sadara.

Fair Value Measurements on a Nonrecurring Basis

2023 Restructuring Program

In the first quarter of 2025, the Company recorded impairment charges of $5 million for asset write-downs and write-offs, included in "Restructuring and asset related charges - net" in the consolidated statements of income and related to Industrial Intermediates & Infrastructure.

NOTE 18 – SEGMENTS AND GEOGRAPHIC REGIONS

Sales to external customers, which are attributed to geographic regions based on customer location, were as follows:

Sales to External Customers by Geographic RegionThree Months Ended
In millionsMar 31, 2025Mar 31, 2024
United States$3,946$3,829
EMEAI3,2743,484
Rest of World3,2113,452
Total$10,431$10,765

Long-lived assets, which are attributed to geographic regions based on asset location, were as follows:

Long-Lived Assets by Geographic RegionMar 31, 2025Dec 31, 2024
In millions
United States$15,176$15,216
EMEAI2,8262,726
Rest of World4,3284,062
Total$22,330$22,004

Dow’s measure of profit/loss for segment reporting purposes is Operating EBIT as this is the manner in which the chief executive officer, chief operating officer, chief financial officer, general counsel and corporate secretary, and senior vice president of corporate development, together the "executive committee" and CODM, assesses performance and allocates resources. The CODM compares quarterly results to both the year-ago and sequential periods to assess performance and allocate resources to each segment. The Company defines Operating EBIT as earnings (i.e., "Income (loss) before income taxes") before interest, excluding the impact of significant items. Operating EBIT by segment includes all operating items relating to the businesses; items that principally apply to Dow as a whole are assigned to Corporate.

Table of Contents

Segment Operating EBIT 1Pack. & Spec. PlasticsInd. Interm. & Infrast.Perf. Materials & CoatingsOperating Segment Total
In millions
Three months ended Mar 31, 2025
Net sales$5,310$2,855$2,071$10,236
Cost of sales4,7652,8221,8459,432
SARD 2240127151518
Equity in earnings (losses) of nonconsolidated affiliates39(58)—(19)
Other segment income (expense) items 3(2)24(26)(4)
Segment Operating EBIT 4$342$(128)$49$263
Three months ended Mar 31, 2024
Net sales$5,430$3,008$2,152$10,590
Cost of sales4,5972,7761,8949,267
SARD 2255136197588
Equity in earnings (losses) of nonconsolidated affiliates25(15)616
Other segment income (expense) items 326(26)(18)
Segment Operating EBIT 4$605$87$41$733

1.Significant expense categories are presented on an operating basis, net of the impact of significant items.

2.SARD includes selling, general and administrative and research and development expenses.

3.Other segment items includes amortization of intangibles and sundry income (expense) - net.

4.Segment Operating EBIT for TDCC for the three months ended March 31, 2025 and 2024 is substantially the same as that of Dow Inc. and therefore is not disclosed separately in the table above. A reconciliation of "Segment Operating EBIT" to "Income before income taxes" is provided in the following table.

Reconciliation of "Segment Operating EBIT" to "Income (Loss) Before Income Taxes"Three Months Ended
In millionsMar 31, 2025Mar 31, 2024
Segment Operating EBIT$263$733
+ Corporate Operating EBIT(33)(59)
+ Interest income2865
- Interest expense and amortization of debt discount216199
+ Significant items(416)(91)
Income (loss) before income taxes$(374)$449
Other Segment InformationPack. & Spec. PlasticsInd. Interm. & Infrast.Perf. Materials & CoatingsOperating Segment TotalCorp. 1Total
In millions
Three months ended Mar 31, 2025
Net sales$5,310$2,855$2,071$10,236$195$10,431
Depreciation and amortization$360$146$200$706$8$714
Capital expenditures$515$129$41$685$—$685
Operating EBIT$342$(128)$49$263$(33)$230
Three months ended Mar 31, 2024
Net sales$5,430$3,008$2,152$10,590$175$10,765
Depreciation and amortization$371$147$193$711$9$720
Capital expenditures$469$162$83$714$—$714
Operating EBIT$605$87$41$733$(59)$674

1.Corporate contains the reconciliation between the totals for the operating segments and the Company's totals. Net sales for Corporate are primarily related to insurance operations. Corporate expenses are primarily related to insurance operations, salaries and wages and non-business aligned environmental and legal costs.

Table of Contents

Segment Asset InformationPack. & Spec. PlasticsInd. Interm. & Infrast.Perf. Materials & CoatingsOperating Segment TotalCorp.Total
In millions
March 31, 2025
Total assets$28,966$11,830$11,370$52,166$5,333$57,499
Investments in nonconsolidated affiliates$740$348$142$1,230$45$1,275
December 31, 2024
Total assets$29,034$11,928$11,170$52,132$5,180$57,312
Investments in nonconsolidated affiliates$711$367$146$1,224$42$1,266

The following tables summarize the pretax impact of significant items by segment excluded from Operating EBIT:

Significant Items by SegmentThree Months Ended Mar 31, 2025
Pack. & Spec. PlasticsInd. Interm. & Infrast.Perf. Materials & CoatingsOperating Segment TotalCorp.Total
In millions
Restructuring, implementation and efficiency costs, and asset related charges - net 1$—$(1)$—$(1)$(50)$(51)
2025 Restructuring Program 2————(207)(207)
Loss on early extinguishment of debt 3————(60)(60)
Indemnification and other transaction related costs 4————(98)(98)
Total$—$(1)$—$(1)$(415)$(416)

1.Includes restructuring charges and implementation and efficiency costs associated with the Company's 2023 Restructuring Program. Also includes impairment charges related to the write-down of certain manufacturing assets, partially offset by an asset related credit adjustment. See Note 4 for additional information.

2.Severance and related benefit costs associated with the Company's 2025 Restructuring Program. See Note 4 for additional information.

3.The Company retired outstanding long-term debt resulting in a loss on early extinguishment. See Note 9 for additional information.

4.Includes charges related to an arbitration settlement agreement for historical product claims from a divested business. See Note 10 for additional information.

Significant Items by SegmentThree Months Ended Mar 31, 2024
Pack. & Spec. PlasticsInd. Interm. & Infrast.Perf. Materials & CoatingsOperating Segment TotalCorp.Total
In millions
Restructuring, implementation and efficiency costs, and asset related charges - net 1$(37)$(8)$—$(45)$(46)$(91)
Total$(37)$(8)$—$(45)$(46)$(91)

1.Includes restructuring charges and implementation and efficiency costs associated with the Company's 2023 Restructuring Program. Also includes impairment charges related to the write-down of certain manufacturing assets.

Table of Contents

Previous: Cover and table of contents · Next: Item 2. MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS.